Alterity Therapeutics Ltd.ASX: ATH

Positive Interim Data from ATH434-202 Phase 2 Clinical Trial

Jul 17, 2024 at 4:20 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment